FABP4 has been implicated in cardiometabolic disease: a SNP which increases FABP4 was found to raise the odds of type II diabetes among adults [42], potentially through its contribution to higher insulin resistance [43]. This evidence concerns the gene FABP4 and Insulin resistance.